ENTITY
JD Health International

JD Health International (6618 HK)

336
Analysis
Consumer StaplesChina
JD Health International Inc. operates drug stores. The Company retails Chinese and Western medicines, nutrition products, health care products, and other products. JD Health International markets its products throughout China.
more
Refresh
bearishJD Health International 21 Aug 2023 08:55

JD Health (6618.HK) 23H1 - The Beautiful Story Is Over; It's Time to Face Reality

We had anticipated JD Health's declining growth in previous insights, but 23Q2 performance was indeed ugly. JD Health's facing dilemmas in policies...

Share
bullishJD Health International 18 Aug 2023 08:33

[JD Health (6618 HK, BUY, TP HK$65) TP Change]: Benefit of Alternative Channel Starts to Show

With years of tightening NDRL and the recent hardline anti-corruption campaign, more pharmaceuticals and patients are looking for alternative...

bearishJD Health International 17 Aug 2023 12:52

JD Health 1H2023: Reports Operating Profits; Margin Upside Is Very Limited

Though JD Health made an OPM of 5.7% in 1Q2023, 1H2023 OPM was 3.5% in line with our analysis that OPM in excess of 2-3% may not be possible in the...

bearishJD Health International 09 Jun 2023 12:06

JD Health: Profitability Remains Under Pressure

JD Health reported an OPM of 5.7% for 1Q2023. Our quantamental analysis proves that this is one off and may not be able to generate OPM in excess...

bullishJD Health International 16 May 2023 08:55

JD Health (6618.HK) 23Q1 - As Industry Beta Fades, the Expectation Reversal Has yet to Come

As industry beta brought by COVID-19 dividend fades away, JD Health's performance growth would slow down.The current business model cannot support...

Share
x